IDSA
@idsainfo.bsky.social
A global community of 13,000 clinicians, scientists and public health experts working together to solve humanity’s smallest and greatest challenges, from tiny microbes to global outbreaks.
On IDSA’s & HIVMA’s Science Speaks blog: Brendan J. Kelly, MD, MS, reviews an article in Nature that describes a natural experiment on the effect of herpes zoster vaccination on dementia. https://www.idsociety.org/science-speaks-blog/2025/zoster-vaccination-and-protection-against-dementia/
Zoster vaccination and protection against dementia
An article in Nature described a natural experiment on the effect of herpes zoster vaccination on dementia. Read IDSA’s Journal Club review by Brendan J. Kelly, MD, MS.
www.idsociety.org
November 25, 2025 at 2:42 AM
On IDSA’s & HIVMA’s Science Speaks blog: Brendan J. Kelly, MD, MS, reviews an article in Nature that describes a natural experiment on the effect of herpes zoster vaccination on dementia. https://www.idsociety.org/science-speaks-blog/2025/zoster-vaccination-and-protection-against-dementia/
Your name looks better with FIDSA on it. 🌟
Be recognized for your contributions to the field of infectious diseases. Apply to become a Fellow of IDSA (FIDSA) by Dec. 19: https://bit.ly/4qVcnOv
Be recognized for your contributions to the field of infectious diseases. Apply to become a Fellow of IDSA (FIDSA) by Dec. 19: https://bit.ly/4qVcnOv
November 25, 2025 at 2:30 AM
Your name looks better with FIDSA on it. 🌟
Be recognized for your contributions to the field of infectious diseases. Apply to become a Fellow of IDSA (FIDSA) by Dec. 19: https://bit.ly/4qVcnOv
Be recognized for your contributions to the field of infectious diseases. Apply to become a Fellow of IDSA (FIDSA) by Dec. 19: https://bit.ly/4qVcnOv
As #USAAW25 comes to a close, don’t forget your opportunity to strengthen your antimicrobial stewardship expertise with IDSA’s Antimicrobial Stewardship Curricula: bit.ly/3vW515g
Discount available! Use code IDSAAMRWK for 10% off any AS Curriculum purchase during USAAW (11/18–11/24).
Discount available! Use code IDSAAMRWK for 10% off any AS Curriculum purchase during USAAW (11/18–11/24).
November 23, 2025 at 6:22 PM
As #USAAW25 comes to a close, don’t forget your opportunity to strengthen your antimicrobial stewardship expertise with IDSA’s Antimicrobial Stewardship Curricula: bit.ly/3vW515g
Discount available! Use code IDSAAMRWK for 10% off any AS Curriculum purchase during USAAW (11/18–11/24).
Discount available! Use code IDSAAMRWK for 10% off any AS Curriculum purchase during USAAW (11/18–11/24).
New #LetsTalkID out now!🎙️ @matih-id.bsky.social and @drdemetre.bsky.social explore the current state of public health. They discuss how political pressures and weakened infrastructure have left the system vulnerable, and how this could spark a public health “renaissance."
Transcript: bit.ly/4887CZq
Transcript: bit.ly/4887CZq
From Darkness to Opportunity: Reimagining the Future of Public Health
Mati Hlatshwayo Davis, MD, MPH, FIDSA, and former CDC director Demetre Daskalakis MD, MPH, explore the current state of public health.
bit.ly
November 23, 2025 at 2:11 AM
New #LetsTalkID out now!🎙️ @matih-id.bsky.social and @drdemetre.bsky.social explore the current state of public health. They discuss how political pressures and weakened infrastructure have left the system vulnerable, and how this could spark a public health “renaissance."
Transcript: bit.ly/4887CZq
Transcript: bit.ly/4887CZq
On IDSA’s & HIVMA’s Science Speaks blog: Read JID's latest monthly roundup of papers relevant to clinicians, including articles on factors that increase RSV hospitalization risk, how differences in baseline median ANC can impact clinical management and more. https://bit.ly/4rdAjg7
JID for Clinicians: Dosing strategies for TB prevention, a clinical case of MDR C. auris and more
Learn about factors that increase RSV hospitalization risk, how differences in baseline median ANC can impact clinical management and other research ready to inform clinical practice.
bit.ly
November 21, 2025 at 8:53 PM
On IDSA’s & HIVMA’s Science Speaks blog: Read JID's latest monthly roundup of papers relevant to clinicians, including articles on factors that increase RSV hospitalization risk, how differences in baseline median ANC can impact clinical management and more. https://bit.ly/4rdAjg7
Decades of rigorous and scientifically sound research have proven that vaccines do not cause autism. CDC’s decision to change language on its website reversing that finding is reckless & harmful.
Our statement w/ @hivma.bsky.social, APIC, @sheaepi.bsky.social & @sidpharm.bsky.social: bit.ly/3XEc0KH
Our statement w/ @hivma.bsky.social, APIC, @sheaepi.bsky.social & @sidpharm.bsky.social: bit.ly/3XEc0KH
November 21, 2025 at 12:42 AM
Decades of rigorous and scientifically sound research have proven that vaccines do not cause autism. CDC’s decision to change language on its website reversing that finding is reckless & harmful.
Our statement w/ @hivma.bsky.social, APIC, @sheaepi.bsky.social & @sidpharm.bsky.social: bit.ly/3XEc0KH
Our statement w/ @hivma.bsky.social, APIC, @sheaepi.bsky.social & @sidpharm.bsky.social: bit.ly/3XEc0KH
Antibiotic and antifungal drugs are valuable tools for treating infections, but any use can cause side effects and contribute to #antimicrobialresistance.
Learn how the appropriate use of these drugs can help fight AMR: bit.ly/4603t9S #USAAW25
Learn how the appropriate use of these drugs can help fight AMR: bit.ly/4603t9S #USAAW25
November 20, 2025 at 2:50 PM
Antibiotic and antifungal drugs are valuable tools for treating infections, but any use can cause side effects and contribute to #antimicrobialresistance.
Learn how the appropriate use of these drugs can help fight AMR: bit.ly/4603t9S #USAAW25
Learn how the appropriate use of these drugs can help fight AMR: bit.ly/4603t9S #USAAW25
#IDSAGuidelines update! We’ve updated a remark in our 2025 guidance on influenza vaccination in immunocompromised patients (bolded below).
For more information and to view the supporting rationale, visit https://bit.ly/4r2kNnr.
For more information and to view the supporting rationale, visit https://bit.ly/4r2kNnr.
November 19, 2025 at 4:56 PM
#IDSAGuidelines update! We’ve updated a remark in our 2025 guidance on influenza vaccination in immunocompromised patients (bolded below).
For more information and to view the supporting rationale, visit https://bit.ly/4r2kNnr.
For more information and to view the supporting rationale, visit https://bit.ly/4r2kNnr.
Bacterial STI prevention by DoxyPEP in men who have sex with men has raised concerns about antimicrobial drug resistance (AMR). This #USAAW25, read this CID study on the impact of DoxyPEP on Neisseria gonorrhoeae AMR. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf591/8317541
Antimicrobial drug-resistant Neisseria gonorrhoeae (GC) infections in men using doxycycline postexposure prophylaxis. A substudy of the ANRS 174 DOXYVAC trial
Post-exposure doxycycline-based prophylaxis was associated with a significant increase in the frequency of N. gonorrhoeae isolates with high-level resistan
academic.oup.com
November 19, 2025 at 4:45 PM
Bacterial STI prevention by DoxyPEP in men who have sex with men has raised concerns about antimicrobial drug resistance (AMR). This #USAAW25, read this CID study on the impact of DoxyPEP on Neisseria gonorrhoeae AMR. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf591/8317541
Strengthen your antimicrobial stewardship expertise this #USAAW25 with IDSA’s Antimicrobial Stewardship Curricula: bit.ly/3vW515g
Discount available! Use code IDSAAMRWK for 10% off any AS Curriculum purchase during USAAW (11/18–11/24).
Discount available! Use code IDSAAMRWK for 10% off any AS Curriculum purchase during USAAW (11/18–11/24).
November 18, 2025 at 5:56 PM
Strengthen your antimicrobial stewardship expertise this #USAAW25 with IDSA’s Antimicrobial Stewardship Curricula: bit.ly/3vW515g
Discount available! Use code IDSAAMRWK for 10% off any AS Curriculum purchase during USAAW (11/18–11/24).
Discount available! Use code IDSAAMRWK for 10% off any AS Curriculum purchase during USAAW (11/18–11/24).
Get recognized for your impact on the field of ID. Apply to become a Fellow of IDSA (FIDSA).
FIDSA is a designation that recognizes individuals who have achieved professional excellence & provided significant service to the profession.
Apply by Dec. 19: https://bit.ly/4qVcnOv
FIDSA is a designation that recognizes individuals who have achieved professional excellence & provided significant service to the profession.
Apply by Dec. 19: https://bit.ly/4qVcnOv
November 18, 2025 at 1:14 AM
Get recognized for your impact on the field of ID. Apply to become a Fellow of IDSA (FIDSA).
FIDSA is a designation that recognizes individuals who have achieved professional excellence & provided significant service to the profession.
Apply by Dec. 19: https://bit.ly/4qVcnOv
FIDSA is a designation that recognizes individuals who have achieved professional excellence & provided significant service to the profession.
Apply by Dec. 19: https://bit.ly/4qVcnOv
Calling all mid- and senior-career infectious diseases and HIV specialists! Build skills, strategies, and connections to accelerate your career with the Community of Leaders program.
Learn more and apply by Dec. 4: https://bit.ly/3IdDYc6
Learn more and apply by Dec. 4: https://bit.ly/3IdDYc6
November 16, 2025 at 10:10 PM
Calling all mid- and senior-career infectious diseases and HIV specialists! Build skills, strategies, and connections to accelerate your career with the Community of Leaders program.
Learn more and apply by Dec. 4: https://bit.ly/3IdDYc6
Learn more and apply by Dec. 4: https://bit.ly/3IdDYc6
Is your institution a leader in antimicrobial stewardship? Apply for IDSA’s Antimicrobial Stewardship Center of Excellence Program and earn recognition for your efforts.
Applications due Jan. 31, 2026: https://bit.ly/49QCNuy
Applications due Jan. 31, 2026: https://bit.ly/49QCNuy
November 15, 2025 at 12:20 AM
Is your institution a leader in antimicrobial stewardship? Apply for IDSA’s Antimicrobial Stewardship Center of Excellence Program and earn recognition for your efforts.
Applications due Jan. 31, 2026: https://bit.ly/49QCNuy
Applications due Jan. 31, 2026: https://bit.ly/49QCNuy
After a severe case of shingles, Lisa Junker, IDSA senior director of publishing & editorial strategy, knows how serious it can be. Lisa shares her story in this WebMD article, which also highlights findings presented at #IDWeek2025 on shingles vaccines. https://bit.ly/4oCe6Xj
The Vaccine That Adults 50+ Shouldn't Skip
A woman's severe shingles case highlights why experts urge all adults 50 and older to get vaccinated – protection that new research shows may also lower dementia and heart risks.
bit.ly
November 14, 2025 at 8:48 PM
After a severe case of shingles, Lisa Junker, IDSA senior director of publishing & editorial strategy, knows how serious it can be. Lisa shares her story in this WebMD article, which also highlights findings presented at #IDWeek2025 on shingles vaccines. https://bit.ly/4oCe6Xj
IDSA’s updated E/M guide helps ID physicians navigate the 2025 AMA CPT rules, with examples for ID care and details on new add-on code G0545: https://www.idsociety.org/practice-resources/practice-tools/coding-and-payment/
Coding and Payment
www.idsociety.org
November 13, 2025 at 2:48 PM
IDSA’s updated E/M guide helps ID physicians navigate the 2025 AMA CPT rules, with examples for ID care and details on new add-on code G0545: https://www.idsociety.org/practice-resources/practice-tools/coding-and-payment/
IDSA's 2025 IDA&E Progress Report shows how inclusion and equity efforts are taking root across advocacy, programs and partnerships.
Read: https://www.idsociety.org/globalassets/idsa/about-idsa/idae/2025-progress-report.pdf
Read: https://www.idsociety.org/globalassets/idsa/about-idsa/idae/2025-progress-report.pdf
November 12, 2025 at 7:51 PM
IDSA's 2025 IDA&E Progress Report shows how inclusion and equity efforts are taking root across advocacy, programs and partnerships.
Read: https://www.idsociety.org/globalassets/idsa/about-idsa/idae/2025-progress-report.pdf
Read: https://www.idsociety.org/globalassets/idsa/about-idsa/idae/2025-progress-report.pdf
Malaria in pregnancy causes adverse effects on the mother and fetus, requiring effective antimalarial treatment. In CID, authors examine the transplacental transfer of antimalarials to assess fetal safety and the risk of congenital malaria. https://bit.ly/4hSQGup
Transplacental Transfer of Lumefantrine, Mefloquine, and Piperaquine: A Comparison of Concentrations in Mothers, Neonates, and Cord Blood
AbstractBackground. Malaria in pregnancy causes adverse effects on the mother and fetus, requiring effective antimalarial treatment. Understanding the tran
academic.oup.com
November 11, 2025 at 6:31 PM
Malaria in pregnancy causes adverse effects on the mother and fetus, requiring effective antimalarial treatment. In CID, authors examine the transplacental transfer of antimalarials to assess fetal safety and the risk of congenital malaria. https://bit.ly/4hSQGup
Calling all mid- and senior-career infectious diseases and HIV specialists! Build skills, strategies, and connections to accelerate your career with the Community of Leaders program.
Learn more and apply by Dec. 4: https://bit.ly/3IdDYc6
Learn more and apply by Dec. 4: https://bit.ly/3IdDYc6
November 11, 2025 at 1:31 AM
Calling all mid- and senior-career infectious diseases and HIV specialists! Build skills, strategies, and connections to accelerate your career with the Community of Leaders program.
Learn more and apply by Dec. 4: https://bit.ly/3IdDYc6
Learn more and apply by Dec. 4: https://bit.ly/3IdDYc6
On IDSA’s & HIVMA’s Science Speaks blog: Mahreen Anwar, BS; Asad Muhammed, BS; and Shamsuddin Anwar, MD, explore the role of antibiotic stewardship in treating open fractures. https://bit.ly/43oWCFw
Fixing more than bones: The role of antibiotic stewardship in open fractures
Providing effective antibiotic coverage to prevent infections following open fractures while also maintaining antibiotic stewardship to minimize resistance and adverse effects requires a careful balance.
www.idsociety.org
November 10, 2025 at 6:41 PM
On IDSA’s & HIVMA’s Science Speaks blog: Mahreen Anwar, BS; Asad Muhammed, BS; and Shamsuddin Anwar, MD, explore the role of antibiotic stewardship in treating open fractures. https://bit.ly/43oWCFw
From meaningful conversations in our Foundation Lounge to celebrations of diversity and connection, #IDWeek2025 reminded us why this community inspires us. Thank you for supporting the IDSA Foundation and being part of the curiosity and compassion that drives our field forward.✨
November 9, 2025 at 11:59 PM
From meaningful conversations in our Foundation Lounge to celebrations of diversity and connection, #IDWeek2025 reminded us why this community inspires us. Thank you for supporting the IDSA Foundation and being part of the curiosity and compassion that drives our field forward.✨
IDSA VP Max Brito, MD, MPH, FIDSA, represented IDSA at the 24th Brazilian Congress of Infectious Diseases. He joined experts from the Brazilian Ministry of Health & local ID leaders in two joint BSI–IDSA HIV symposia, marking the second year of this growing collaboration.
November 9, 2025 at 9:46 PM
IDSA VP Max Brito, MD, MPH, FIDSA, represented IDSA at the 24th Brazilian Congress of Infectious Diseases. He joined experts from the Brazilian Ministry of Health & local ID leaders in two joint BSI–IDSA HIV symposia, marking the second year of this growing collaboration.
NEW! Live from #IDWeek2025, #LetsTalkID hosts Drs. Buddy Creech, @matih-id.bsky.social & @paulsaxmd.bsky.social share their hottest takes on infectious diseases, from the dismantling of the CDC to breakthroughs in treating staph aureus bacteremia.
Transcript: https://bit.ly/4oAUKlI
Transcript: https://bit.ly/4oAUKlI
Live from IDWeek 2025: Infectious Diseases Hot Takes
Let's Talk ID hosts reunite live at IDWeek 2025 to share their hottest takes on infectious diseases and public health.
bit.ly
November 8, 2025 at 7:16 PM
NEW! Live from #IDWeek2025, #LetsTalkID hosts Drs. Buddy Creech, @matih-id.bsky.social & @paulsaxmd.bsky.social share their hottest takes on infectious diseases, from the dismantling of the CDC to breakthroughs in treating staph aureus bacteremia.
Transcript: https://bit.ly/4oAUKlI
Transcript: https://bit.ly/4oAUKlI
🚨 New #Antimicrobial Agents Alert! 🚨
#IMARI26 is calling for submissions for its New Antimicrobial Agents Session — highlighting novel antibacterial & antifungal compounds in or entering clinical development.
🗓️ Deadline: Dec 1, 2025
🔗 IMARI.org/call-for-abstracts
#IMARI26 is calling for submissions for its New Antimicrobial Agents Session — highlighting novel antibacterial & antifungal compounds in or entering clinical development.
🗓️ Deadline: Dec 1, 2025
🔗 IMARI.org/call-for-abstracts
November 8, 2025 at 1:11 AM
🚨 New #Antimicrobial Agents Alert! 🚨
#IMARI26 is calling for submissions for its New Antimicrobial Agents Session — highlighting novel antibacterial & antifungal compounds in or entering clinical development.
🗓️ Deadline: Dec 1, 2025
🔗 IMARI.org/call-for-abstracts
#IMARI26 is calling for submissions for its New Antimicrobial Agents Session — highlighting novel antibacterial & antifungal compounds in or entering clinical development.
🗓️ Deadline: Dec 1, 2025
🔗 IMARI.org/call-for-abstracts
The shutdown of USAID has devastated global health programs that once saved millions of lives. “Rovina’s Choice” documents this impact through the story of Rovina Naboi, a mother in Kenya struggling to protect her child as aid vanishes. https://bit.ly/480zUGm
The Shutdown of U.S.A.I.D. Has Already Killed Hundreds of Thousands
The short documentary “Rovina’s Choice” tells the story of what goes when aid goes.
bit.ly
November 7, 2025 at 8:25 PM
The shutdown of USAID has devastated global health programs that once saved millions of lives. “Rovina’s Choice” documents this impact through the story of Rovina Naboi, a mother in Kenya struggling to protect her child as aid vanishes. https://bit.ly/480zUGm
On IDSA’s & HIVMA’s Science Speaks blog: Erica Kaufman West, MD, FACP, FIDSA, explores the effects of prophylactic and post-excision human papillomavirus vaccination on recurrent high-grade cervical intraepithelial neoplasia relative to margin status. https://bit.ly/47BoJUB
HPV vaccination: Expanding eligibility to decrease cancer recurrence
A study explored the effects of prophylactic and post-excision HPV vaccination on recurrent high-grade cervical intraepithelial neoplasia relative to margin status. Read IDSA's Journal Club review.
www.idsociety.org
November 6, 2025 at 5:11 PM
On IDSA’s & HIVMA’s Science Speaks blog: Erica Kaufman West, MD, FACP, FIDSA, explores the effects of prophylactic and post-excision human papillomavirus vaccination on recurrent high-grade cervical intraepithelial neoplasia relative to margin status. https://bit.ly/47BoJUB